Cited by 586Cancer, Hypoxia, and MetabolismEpigenetics and DNA MethylationChromatin Remodeling and Cancer

Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transition

Open access
Sciacovelli, Marco, Gonçalves, Emanuel, Johnson, Timothy Isaac, Zecchini, Vincent Roberto, da Costa, Ana Sofia Henriques, Gaude, Edoardo, Drubbel, Alizee Vercauteren, Theobald, Sebastian Julian +16 more·2016·Nature

Abstract

Mutations of the tricarboxylic acid cycle enzyme fumarate hydratase cause hereditary leiomyomatosis and renal cell cancer. Fumarate hydratase-deficient renal cancers are highly aggressive and metastasize even when small, leading to a very poor clinical outcome. Fumarate, a small molecule metabolite that accumulates in fumarate hydratase-deficient cells, plays a key role in cell transformation, making it a bona fide oncometabolite. Fumarate has been shown to inhibit α-ketoglutarate-dependent dioxygenases that are involved in DNA and histone demethylation. However, the link between fumarate accumulation, epigenetic changes, and tumorigenesis is unclear. Here we show that loss of fumarate hydratase and the subsequent accumulation of fumarate in mouse and human cells elicits an epithelial-to-mesenchymal-transition (EMT), a phenotypic switch associated with cancer initiation, invasion, and metastasis. We demonstrate that fumarate inhibits Tet-mediated demethylation of a regulatory region of the antimetastatic miRNA cluster mir-200ba429, leading to the expression of EMT-related transcription factors and enhanced migratory properties. These epigenetic and phenotypic changes are recapitulated by the incubation of fumarate hydratase-proficient cells with cell-permeable fumarate. Loss of fumarate hydratase is associated with suppression of miR-200 and the EMT signature in renal cancer and is associated with poor clinical outcome. These results imply that loss of fumarate hydratase and fumarate accumulation contribute to the aggressive features of fumarate hydratase-deficient tumours.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nature19353

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • High fumarate inhibits TET enzymes, stimulating EMT and leading to cancer metastasis.

    “In addition, fumarate inhibits TET enzymes, which stimulate EMT, leading to cancer metastasis131,132.”

    From Glutamine reliance in cell metabolism (2020) · cites this paper as [131]

  • Restoring fumarate hydratase function in tumor cells causes loss of ability to invade and migrate.

    “Further confirmation of fumarate as an oncometabolite was verified by experimental data showing that tumor cells lost their ability to invade and migrate when the function of fumarate hydratase was restored by an external expression vector131.”

    From Glutamine reliance in cell metabolism (2020) · cites this paper as [131]

  • Mutations in IDH1/2 are the most frequently mutated metabolic genes in human cancer.

    “In recent years, two landmark genomic studies carried out in human glioma and acute myeloid leukaemia (AML) found mutations in IDH1/2 and it is now appreciated that these enzymes (which drive elevated production of D-2-HG) are the most frequently mutated metabolic genes in human cancer112-114.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Sciacovelli, M., Gonçalves, E., Johnson, T. I., Zecchini, V. R., da Costa, A. S. H., Gaude, E., Drubbel, A. V., Theobald, S. J., Abbo, S. R., Tran, M. G. B., Rajeeve, V., Cardaci, S., Foster, S., Yun, H., Cutillas, P., Warren, A., Gnanapragasam, V., Gottlieb, E., Franze, K., Huntly, B., Maher, E. R., Maxwell, P. H., Saez-Rodriguez, J., & Frezza, C.
Affiliations
  • University of Cambridge (GB)
  • European Bioinformatics Institute (GB)
  • Queen Mary University of London (GB)
  • Cancer Research UK Scotland Institute (GB)
  • Wellcome/MRC Cambridge Stem Cell Institute (GB)
Corresponding author
Frezza, Christian
Venue
Nature
Published
2016-08-31
Volume
537
Issue
7621
Pages
544-547
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W2513105811
Cited by
584
References
40
Citations by year
2026: 56 · 2025: 49 · 2024: 61 · 2023: 54 · 2022: 64 · 2021: 60 · 2020: 56 · 2019: 59 · 2018: 55 · 2017: 55 · 2016: 14
FWCI
25.67
Type
journal article
Language
en
Open access
Locations
  • Nature (publishedVersion)
  • PubMed (publishedVersion)
  • Apollo (University of Cambridge) (acceptedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion)
  • Socio-Environmental Systems Modeling (acceptedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
  • UCL Discovery (University College London) (submittedVersion)
  • RWTH Publications (RWTH Aachen) (submittedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • Apollo
Funders
  • Wellcome Trust (096956/Z/11/Z)
  • Cancer Research UK (18278)
  • National Institute for Health and Care Research (NF-SI-0514-10122)
  • Medical Research Council (MC_PC_12009, MR/M010392/1, MC_UU_12022/6)
  • Cancer Research UK Cambridge Institute, University of Cambridge
  • National Cancer Institute
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
Keywords
fumarate, fumarate hydratase, epithelial-mesenchymal transition, oncometabolites, TCA cycle, DNA demethylation, histone demethylation, alpha-ketoglutarate-dependent dioxygenase, miR-200 family, miR-429, metastasis, renal cell carcinoma, hereditary leiomyomatosis and renal cell carcinoma, cell migration, epigenetic modifications
MeSH terms
Animals, Cell Movement, Cells, Cultured, Fumarate Hydratase, Fumarates, Humans, Kidney Neoplasms, Mesoderm, Transcription Factors, MicroRNAs, Epigenesis, Genetic, Mice, HEK293 Cells, Epithelial-Mesenchymal Transition, Transcriptome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review